RON MARTELL
CIK 1177079 · President, CEO and Director · last filed 2026-01-05
RON MARTELL is a President, CEO and Director who has filed 39 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for JSPRW, was dated Jan 5, 2026. Across all open-market trades the lifetime net is +$114.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $993 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$993
4
39
$114.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JSPRW | President, CEO and Director | 74,118 | $0.01 | $993 | $99.6K | 12 | 2026-01-05 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | Director | — | — | — | $0 | 1 | 2017-01-27 |
| HUMANIGEN, INC (KBIO) Delisted | Executive Chairman | — | — | — | $0 | 7 | 2015-10-28 |
| PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Chief Executive Officer | 548,073 | — | — | $15.0K | 14 | 2011-10-07 |
Recent Filings
39 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-05 | JSPRW | Grant (A) | — | $0 | EDGAR |
| 2025-09-24 | JSPRW | Buy (P) | +41,000 | $99.6K | EDGAR |
| 2025-06-06 | JSPRW | Grant (A) | — | $0 | EDGAR |
| 2025-02-18 | JSPRW | Grant (A) | — | $0 | EDGAR |
| 2024-06-12 | JSPRW | Grant (A) | — | $0 | EDGAR |
| 2024-02-20 | JSPRW | Grant (A) | — | $0 | EDGAR |
| 2023-10-13 | JSPRW | Tax (F) | −87,531 | -$74.4K | EDGAR |
| 2023-04-14 | JSPRW | Tax (F) | −87,531 | -$127.8K | EDGAR |
| 2023-03-20 | JSPRW | Grant (A) | — | $0 | EDGAR |
| 2023-02-03 | JSPRW | Grant (A) | — | $0 | EDGAR |